Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Essence (BIOE) Shares Outstanding (Weighted Average) (2020 - 2025)

Bio Essence has reported Shares Outstanding (Weighted Average) over the past 6 years, most recently at $38.0 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $38.0 million for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $38.0 million (changed 0.0% YoY), and the annual figure for FY2025 was $38.0 million, changed 0.0%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $38.0 million at Bio Essence, roughly flat from $38.0 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for BIOE hit a ceiling of $38.0 million in Q1 2024 and a floor of $33.0 million in Q1 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $33.9 million (2023), compared with a mean of $35.2 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): decreased 0.23% in 2021 and later increased 15.15% in 2024.
  • Bio Essence's Shares Outstanding (Weighted Average) stood at $33.0 million in 2021, then changed by 0.0% to $33.0 million in 2022, then increased by 2.86% to $34.0 million in 2023, then rose by 11.94% to $38.0 million in 2024, then changed by 0.0% to $38.0 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $38.0 million (Q4 2025), $38.0 million (Q3 2025), and $38.0 million (Q2 2025) per Business Quant data.